Drawing for CYTONAUT

USPTO serial 97356387

CYTONAUT

Reviewed by CopyMark Law Group

Reg. 7066306Status 700Registered
Filing date
Status date
Registration date
May 30, 2023
Examiner
ADORNO SANTOS, LUZ M.
Law office
PETITIONS OFFICE

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CYTONAUT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Pina Campagna

Pina Campagna CARTER, DELUCA AND FARRELL LLP576 BROAD HOLLOW RD.MELVILLE, NY 11747UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Design, installation, updating, maintenance of computer software used in connected medical devices except sofware for evaluating and treating vision disorders; design, installation, updating, maintenance of computer software used for biological, chemical and medical analysis except sofware for evaluating and treating vision disorders; design, installation, updating, maintenance of computer software used for medical diagnosis except sofware for evaluating and treating vision disorders; design, installation, updating, maintenance of computer software in the medical field except sofware for evaluating and treating vision disorders; Software as a Service (SaaS) featuring software for biological, chemical and medical analysis and for medical diagnosis except sofware for evaluating and treating vision disorders; scientific and technological services, namely, scientific research and conception services, namely, design in the field of pharmaceutical, chemical, and biotechnology research, and biological, chemical and medical analysis; chemical analysis services; biological research; bacteriological research; chemical research; medical research; scientific research; scientific laboratory services;research and development of new products for third parties in the fields of biological, chemical and medical analysis and medical diagnosis; biochemical research and development; pharmaceutical, biomedical and biotechnological research and development; laboratory research, analysis, evaluation, development and clinical testing in particular conducting clinical trials for others of therapeutic, preventive and diagnostic compositions and treatments; conducting scientific and medical research for others; consulting services in the fields of pharmaceutical, chemical, and biotechnology research; chemical substances synthesis services, namely, custom design and development of chemical substances for medical, scientific, and technological applications; chemical and biological development services, namely, development of biochemical, genetic and transcriptomic assays; chemical and biological laboratory services; conducting chemical and biological analyses; customized conception in particular, custom design and development of chemical reagentsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 30, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 30, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 4, 2023CHPBPOST PUBLICATION AMENDMENT - ENTERED—
May 1, 2023APETASSIGNED TO PETITION STAFF—
Apr 11, 2023EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Mar 14, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 14, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 22, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 7, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 7, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Feb 7, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 7, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 7, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 20, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 20, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 20, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 19, 2022DOCKASSIGNED TO EXAMINER—
Apr 15, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 14, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance